HEADER TRANSFERASE/TRANSFERASE INHIBITOR 05-SEP-19 6KVS TITLE STAPHYLOCOCCUS AUREUS FABH WITH COVALENT INHIBITOR OXA1 COMPND MOL_ID: 1; COMPND 2 MOLECULE: 3-OXOACYL-[ACYL-CARRIER-PROTEIN] SYNTHASE 3; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: KETOACYL-ACP SYNTHASE III, 3-OXOACYL-[ACYL-CARRIER-PROTEIN] COMPND 5 SYNTHASE III,BETA-KETOACYL-ACP SYNTHASE III,KAS III; COMPND 6 EC: 2.3.1.180; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: STAPHYLOCOCCUS AUREUS (STRAIN MU3 / ATCC SOURCE 3 700698); SOURCE 4 ORGANISM_TAXID: 418127; SOURCE 5 STRAIN: MU3 / ATCC 700698; SOURCE 6 GENE: FABH, SAHV_0978; SOURCE 7 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS COVALENT INHIBITOR, COMPLEX, KETOACYL-ACP SYNTHASE III, ANTIBIOTIC, KEYWDS 2 TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR Y.YUAN,J.WANG REVDAT 2 22-NOV-23 6KVS 1 REMARK REVDAT 1 09-SEP-20 6KVS 0 JRNL AUTH X.QIU,A.E.CHOUDHRY JRNL TITL CRYSTAL STRUCTURE OF S. AUREUS FABH, BETA-KETOACYL CARRIER JRNL TITL 2 PROTEIN SYNTHASE JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 2.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0238 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 22.14 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.3 REMARK 3 NUMBER OF REFLECTIONS : 27706 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.202 REMARK 3 R VALUE (WORKING SET) : 0.198 REMARK 3 FREE R VALUE : 0.262 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1471 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.30 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.36 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1991 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 98.31 REMARK 3 BIN R VALUE (WORKING SET) : 0.2660 REMARK 3 BIN FREE R VALUE SET COUNT : 109 REMARK 3 BIN FREE R VALUE : 0.3340 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4746 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 36 REMARK 3 SOLVENT ATOMS : 261 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 25.79 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.03000 REMARK 3 B22 (A**2) : -0.01000 REMARK 3 B33 (A**2) : 0.03000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.200 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.264 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.000 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 0.003 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.929 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.868 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): NULL ; NULL ; NULL REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): NULL ; NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): NULL ; NULL ; NULL REMARK 3 GENERAL PLANES REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: U VALUES : REFINED INDIVIDUALLY REMARK 4 REMARK 4 6KVS COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 11-SEP-19. REMARK 100 THE DEPOSITION ID IS D_1300013145. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 19-DEC-18 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.4-5.8 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : SEALED TUBE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : OXFORD DIFFRACTION NOVA REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.54056 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : RIGAKU HYPIC-6000HE REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 29342 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.300 REMARK 200 RESOLUTION RANGE LOW (A) : 22.400 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.6 REMARK 200 DATA REDUNDANCY : 4.600 REMARK 200 R MERGE (I) : 0.06700 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 14.3900 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.30 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.38 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.34400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 1ZOW REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 48.75 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.40 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 4000 SODIUM CITRATE AMMOINIUM REMARK 280 ACETATE, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 291.15K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 32.37700 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 54.90550 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 45.78650 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 54.90550 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 32.37700 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 45.78650 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3870 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 21770 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -28.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OD1 ASP B 529 NH2 ARG B 564 1.93 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 CYS A 425 C - N - CA ANGL. DEV. = 16.7 DEGREES REMARK 500 HIS A 551 CB - CA - C ANGL. DEV. = 13.2 DEGREES REMARK 500 CYS B 425 C - N - CA ANGL. DEV. = 15.2 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 MET A 388 143.43 -179.90 REMARK 500 THR A 395 35.38 -141.04 REMARK 500 ALA A 423 32.40 -140.78 REMARK 500 ALA A 424 -141.60 57.15 REMARK 500 LEU A 503 101.38 -165.16 REMARK 500 ALA A 553 -40.09 -141.56 REMARK 500 SER A 583 -114.20 49.40 REMARK 500 ASP A 603 -0.77 82.13 REMARK 500 MET B 388 139.28 -171.16 REMARK 500 THR B 395 33.30 -141.55 REMARK 500 ALA B 424 -143.91 55.66 REMARK 500 CYS B 425 -37.33 -29.45 REMARK 500 LEU B 503 109.72 -161.90 REMARK 500 SER B 542 -54.86 -23.94 REMARK 500 ALA B 553 -40.79 -157.92 REMARK 500 SER B 583 -127.58 51.72 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 LEU A 469 PHE A 470 -148.74 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue OAX A 701 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide OAX E 701 and CYS E REMARK 800 425 DBREF 6KVS A 314 626 UNP A7X0K2 FABH_STAA1 1 313 DBREF 6KVS B 314 626 UNP A7X0K2 FABH_STAA1 1 313 SEQRES 1 A 313 MET ASN VAL GLY ILE LYS GLY PHE GLY ALA TYR ALA PRO SEQRES 2 A 313 GLU LYS ILE ILE ASP ASN ALA TYR PHE GLU GLN PHE LEU SEQRES 3 A 313 ASP THR SER ASP GLU TRP ILE SER LYS MET THR GLY ILE SEQRES 4 A 313 LYS GLU ARG HIS TRP ALA ASP ASP ASP GLN ASP THR SER SEQRES 5 A 313 ASP LEU ALA TYR GLU ALA SER VAL LYS ALA ILE ALA ASP SEQRES 6 A 313 ALA GLY ILE GLN PRO GLU ASP ILE ASP MET ILE ILE VAL SEQRES 7 A 313 ALA THR ALA THR GLY ASP MET PRO PHE PRO THR VAL ALA SEQRES 8 A 313 ASN MET LEU GLN GLU ARG LEU GLY THR GLY LYS VAL ALA SEQRES 9 A 313 SER MET ASP GLN LEU ALA ALA CYS SER GLY PHE MET TYR SEQRES 10 A 313 SER MET ILE THR ALA LYS GLN TYR VAL GLN SER GLY ASP SEQRES 11 A 313 TYR HIS ASN ILE LEU VAL VAL GLY ALA ASP LYS LEU SER SEQRES 12 A 313 LYS ILE THR ASP LEU THR ASP ARG SER THR ALA VAL LEU SEQRES 13 A 313 PHE GLY ASP GLY ALA GLY ALA VAL ILE ILE GLY GLU VAL SEQRES 14 A 313 SER GLU GLY ARG GLY ILE ILE SER TYR GLU MET GLY SER SEQRES 15 A 313 ASP GLY THR GLY GLY LYS HIS LEU TYR LEU ASP LYS ASP SEQRES 16 A 313 THR GLY LYS LEU LYS MET ASN GLY ARG GLU VAL PHE LYS SEQRES 17 A 313 PHE ALA VAL ARG ILE MET GLY ASP ALA SER THR ARG VAL SEQRES 18 A 313 VAL GLU LYS ALA ASN LEU THR SER ASP ASP ILE ASP LEU SEQRES 19 A 313 PHE ILE PRO HIS GLN ALA ASN ILE ARG ILE MET GLU SER SEQRES 20 A 313 ALA ARG GLU ARG LEU GLY ILE SER LYS ASP LYS MET SER SEQRES 21 A 313 VAL SER VAL ASN LYS TYR GLY ASN THR SER ALA ALA SER SEQRES 22 A 313 ILE PRO LEU SER ILE ASP GLN GLU LEU LYS ASN GLY LYS SEQRES 23 A 313 LEU LYS ASP ASP ASP THR ILE VAL LEU VAL GLY PHE GLY SEQRES 24 A 313 GLY GLY LEU THR TRP GLY ALA MET THR ILE LYS TRP GLY SEQRES 25 A 313 LYS SEQRES 1 B 313 MET ASN VAL GLY ILE LYS GLY PHE GLY ALA TYR ALA PRO SEQRES 2 B 313 GLU LYS ILE ILE ASP ASN ALA TYR PHE GLU GLN PHE LEU SEQRES 3 B 313 ASP THR SER ASP GLU TRP ILE SER LYS MET THR GLY ILE SEQRES 4 B 313 LYS GLU ARG HIS TRP ALA ASP ASP ASP GLN ASP THR SER SEQRES 5 B 313 ASP LEU ALA TYR GLU ALA SER VAL LYS ALA ILE ALA ASP SEQRES 6 B 313 ALA GLY ILE GLN PRO GLU ASP ILE ASP MET ILE ILE VAL SEQRES 7 B 313 ALA THR ALA THR GLY ASP MET PRO PHE PRO THR VAL ALA SEQRES 8 B 313 ASN MET LEU GLN GLU ARG LEU GLY THR GLY LYS VAL ALA SEQRES 9 B 313 SER MET ASP GLN LEU ALA ALA CYS SER GLY PHE MET TYR SEQRES 10 B 313 SER MET ILE THR ALA LYS GLN TYR VAL GLN SER GLY ASP SEQRES 11 B 313 TYR HIS ASN ILE LEU VAL VAL GLY ALA ASP LYS LEU SER SEQRES 12 B 313 LYS ILE THR ASP LEU THR ASP ARG SER THR ALA VAL LEU SEQRES 13 B 313 PHE GLY ASP GLY ALA GLY ALA VAL ILE ILE GLY GLU VAL SEQRES 14 B 313 SER GLU GLY ARG GLY ILE ILE SER TYR GLU MET GLY SER SEQRES 15 B 313 ASP GLY THR GLY GLY LYS HIS LEU TYR LEU ASP LYS ASP SEQRES 16 B 313 THR GLY LYS LEU LYS MET ASN GLY ARG GLU VAL PHE LYS SEQRES 17 B 313 PHE ALA VAL ARG ILE MET GLY ASP ALA SER THR ARG VAL SEQRES 18 B 313 VAL GLU LYS ALA ASN LEU THR SER ASP ASP ILE ASP LEU SEQRES 19 B 313 PHE ILE PRO HIS GLN ALA ASN ILE ARG ILE MET GLU SER SEQRES 20 B 313 ALA ARG GLU ARG LEU GLY ILE SER LYS ASP LYS MET SER SEQRES 21 B 313 VAL SER VAL ASN LYS TYR GLY ASN THR SER ALA ALA SER SEQRES 22 B 313 ILE PRO LEU SER ILE ASP GLN GLU LEU LYS ASN GLY LYS SEQRES 23 B 313 LEU LYS ASP ASP ASP THR ILE VAL LEU VAL GLY PHE GLY SEQRES 24 B 313 GLY GLY LEU THR TRP GLY ALA MET THR ILE LYS TRP GLY SEQRES 25 B 313 LYS HET OAX A 701 18 HET OAX B 701 18 HETNAM OAX 4-CHLORANYL-N-[[CYCLOPROPYLMETHYL(METHANOYL) HETNAM 2 OAX AMINO]METHYL]BENZAMIDE FORMUL 3 OAX 2(C13 H15 CL N2 O2) FORMUL 5 HOH *261(H2 O) HELIX 1 AA1 ALA A 333 PHE A 338 5 6 HELIX 2 AA2 SER A 342 GLY A 351 1 10 HELIX 3 AA3 ASP A 363 GLY A 380 1 18 HELIX 4 AA4 GLN A 382 ILE A 386 5 5 HELIX 5 AA5 THR A 402 GLY A 412 1 11 HELIX 6 AA6 ALA A 423 CYS A 425 5 3 HELIX 7 AA7 SER A 426 SER A 441 1 16 HELIX 8 AA8 SER A 456 THR A 459 5 4 HELIX 9 AA9 ASP A 463 VAL A 468 1 6 HELIX 10 AB1 GLY A 497 LYS A 501 5 5 HELIX 11 AB2 ASN A 515 ALA A 538 1 24 HELIX 12 AB3 THR A 541 ILE A 545 5 5 HELIX 13 AB4 ASN A 554 GLY A 566 1 13 HELIX 14 AB5 SER A 568 MET A 572 5 5 HELIX 15 AB6 SER A 575 GLY A 580 1 6 HELIX 16 AB7 THR A 582 ALA A 584 5 3 HELIX 17 AB8 ALA A 585 ASN A 597 1 13 HELIX 18 AB9 ALA B 333 PHE B 338 5 6 HELIX 19 AC1 SER B 342 GLY B 351 1 10 HELIX 20 AC2 ASP B 363 GLY B 380 1 18 HELIX 21 AC3 GLN B 382 ILE B 386 5 5 HELIX 22 AC4 THR B 402 GLY B 412 1 11 HELIX 23 AC5 ALA B 423 CYS B 425 5 3 HELIX 24 AC6 SER B 426 SER B 441 1 16 HELIX 25 AC7 SER B 456 THR B 459 5 4 HELIX 26 AC8 ASP B 463 VAL B 468 1 6 HELIX 27 AC9 GLY B 497 LYS B 501 5 5 HELIX 28 AD1 ASN B 515 ALA B 538 1 24 HELIX 29 AD2 THR B 541 ILE B 545 5 5 HELIX 30 AD3 ASN B 554 LEU B 565 1 12 HELIX 31 AD4 SER B 568 MET B 572 5 5 HELIX 32 AD5 SER B 575 GLY B 580 1 6 HELIX 33 AD6 THR B 582 ALA B 584 5 3 HELIX 34 AD7 ALA B 585 ASN B 597 1 13 SHEET 1 AA110 VAL A 316 TYR A 324 0 SHEET 2 AA110 ASP A 472 GLU A 481 -1 O ALA A 474 N TYR A 324 SHEET 3 AA110 ILE A 447 LYS A 454 -1 N ILE A 447 O ILE A 479 SHEET 4 AA110 ILE A 389 ALA A 392 1 N ALA A 392 O VAL A 450 SHEET 5 AA110 SER A 418 LEU A 422 1 O MET A 419 N VAL A 391 SHEET 6 AA110 SER B 418 LEU B 422 -1 O ASP B 420 N LEU A 422 SHEET 7 AA110 MET B 388 ALA B 392 1 N VAL B 391 O GLN B 421 SHEET 8 AA110 ILE B 447 LYS B 454 1 O VAL B 450 N ALA B 392 SHEET 9 AA110 ASP B 472 GLU B 481 -1 O ILE B 479 N ILE B 447 SHEET 10 AA110 VAL B 316 TYR B 324 -1 N GLY B 317 O GLY B 480 SHEET 1 AA2 2 LYS A 328 ASP A 331 0 SHEET 2 AA2 2 GLU A 354 TRP A 357 -1 O ARG A 355 N ILE A 330 SHEET 1 AA3 4 GLY A 487 SER A 495 0 SHEET 2 AA3 4 THR A 616 LYS A 623 -1 O LYS A 623 N GLY A 487 SHEET 3 AA3 4 THR A 605 GLY A 612 -1 N ILE A 606 O ILE A 622 SHEET 4 AA3 4 LEU A 547 PRO A 550 1 N ILE A 549 O VAL A 607 SHEET 1 AA4 2 LEU A 503 LEU A 505 0 SHEET 2 AA4 2 LEU A 512 MET A 514 -1 O LYS A 513 N TYR A 504 SHEET 1 AA5 2 LYS B 328 ASP B 331 0 SHEET 2 AA5 2 GLU B 354 TRP B 357 -1 O ARG B 355 N ILE B 330 SHEET 1 AA6 4 GLY B 487 SER B 495 0 SHEET 2 AA6 4 THR B 616 LYS B 623 -1 O LYS B 623 N GLY B 487 SHEET 3 AA6 4 THR B 605 GLY B 612 -1 N ILE B 606 O ILE B 622 SHEET 4 AA6 4 LEU B 547 PRO B 550 1 N ILE B 549 O VAL B 607 SHEET 1 AA7 2 LEU B 503 LEU B 505 0 SHEET 2 AA7 2 LEU B 512 MET B 514 -1 O LYS B 513 N TYR B 504 LINK SG CYS A 425 C4 OAX A 701 1555 1555 1.70 LINK SG CYS B 425 C4 OAX B 701 1555 1555 1.71 CISPEP 1 PHE A 400 PRO A 401 0 -16.14 CISPEP 2 GLY A 614 LEU A 615 0 5.33 CISPEP 3 PHE B 400 PRO B 401 0 -9.20 CISPEP 4 GLY B 614 LEU B 615 0 -8.18 SITE 1 AC1 13 ALA A 424 CYS A 425 PHE A 470 LEU A 503 SITE 2 AC1 13 MET A 514 VAL A 519 ALA A 553 ILE A 557 SITE 3 AC1 13 ASN A 581 SER A 583 GLY A 612 GLY A 613 SITE 4 AC1 13 PHE B 400 SITE 1 AC2 17 PHE A 400 ALA B 423 ALA B 424 SER B 426 SITE 2 AC2 17 GLY B 427 LEU B 455 PHE B 470 LEU B 503 SITE 3 AC2 17 MET B 514 HIS B 551 ALA B 553 ILE B 557 SITE 4 AC2 17 ASN B 581 SER B 583 PHE B 611 GLY B 612 SITE 5 AC2 17 GLY B 613 CRYST1 64.754 91.573 109.811 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015443 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010920 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009107 0.00000